Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
33%
Ph not_applicable
3
33%
Ph phase_1
3
33%

Phase Distribution

3

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(2)
Other(5)

Detailed Status

unknown5
Recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (33.3%)
Phase 23 (33.3%)
N/A3 (33.3%)

Trials by Status

recruiting222%
unknown556%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
RADIATION
Total Trials
9